Endocervical adenocarcinoma of the gastric type: a case report and literature review., PMID:40432921
Proteolytic degradation of Beta-Ig H3 (βigH3/TGFBI) can be quantified non-invasively in serum and predicts prognosis in patients with advanced pancreatic ductal adenocarcinoma., PMID:40394523
Modulation of Aggregation of Covalent Organic Framework Nanosheets with Aggregation-Induced Emission Activity for Ultrasensitive No-Wash Fluorescent Immunosensor., PMID:40377048
CA19-9/DBil: a promising indicator to distinguish between CA19-9-elevated pancreatic head-type autoimmune pancreatitis and pancreatic head cancer., PMID:40301736
Ping pong chrysanthemum-like Bi-BiOI and ternary core-shell structured Pd@AuPt based dual-electric signal outputs biosensor for accurate detection of CA19 - 9., PMID:40261434
Graphitic carbon nitride/1-pyrenebutyric acid N-hydroxysuccinimide/polythiophene nanocomposite photoelectrochemical biosensor for CA 19-9 detection., PMID:40253965
Screening colorectal cancer associated autoantigens through multi-omics analysis and diagnostic performance evaluation of corresponding autoantibodies., PMID:40240912
CD44 identified as a diagnostic biomarker for highly malignant CA19-9 negative pancreatic cancer., PMID:40216152
Pathological complete response following addition of durvalumab to gemcitabine and cisplatin therapy for intrahepatic cholangiocarcinoma with Lynch syndrome-associated mismatch repair deficiency., PMID:40210796
Autoantibodies as Potential Liquid Biopsy Biomarker in Detection of Pancreatic Cancer: A Diagnostic Test Accuracy Review and Meta-Analysis., PMID:40185645
Rapid and Sensitive Detection of Thrombospondin-2 Using Nanoparticle Sensors for Cancer Screening and Prognosis., PMID:40141965
Establishment of GDF15 time-resolved fluorescence immunoassay and its clinical application in colorectal cancer., PMID:40118237
[A Case of Duodenal Cancer with a History of Metachronous Multiple Colorectal Cancer Resections Achieving Endoscopic Complete Response following Pembrolizumab Treatment]., PMID:40073890
From interference to insight: pseudo-lipidemia led to the diagnosis of Waldenström macroglobulinemia., PMID:40065247
Gold Nanoparticle Incorporated Graphene Oxide as a SERS Platform for Ultratrace Antibody Free Sensing of the Cancer Biomarker CEA., PMID:40062598
Multiplexed glycan immunofluorescence identification of pancreatic cancer cell subpopulations in both tumor and blood samples., PMID:40053601
Case report: Chemotherapy plus sintilimab for the treatment of gastroesophageal junction hepatoid adenocarcinoma with liver metastasis: a case study with literature review., PMID:39931054
Pyridylboronic Acid- and Poly(ethylene glycol)-Functionalized PEDOT Copolymers for Electrochemical Detection of Sialic Acid-Rich Cancer Biomarkers in Serum., PMID:39909825
Differential expression of CD175 and CA19-9 in pancreatic adenocarcinoma., PMID:39905057
MUC1 and glycan probing of CA19-9 captured biomarkers from cyst fluids and serum provides enhanced recognition of ovarian cancer., PMID:39863644
Subtype-specific human endogenous retrovirus K102 envelope protein is a novel serum immunosuppressive biomarker of cancer., PMID:39850893
Biomarker detection based on nanoparticle-induced ultrasonic Rayleigh scattering., PMID:39632870
Optical immunosensor panel using quantum dot-antibody conjugates for highly sensitive detection of carbohydrate antigen 19-9 (CA19-9)., PMID:39615916
A simple SERS sensor based on antibody-modified Fe3O4@Au MNPs for the detection of CA19-9 in CRC patients., PMID:39569653
Exploring the Interplay Between Radioimmunoconjugates and Fcγ Receptors in Genetically Engineered Mouse Models of Cancer., PMID:39539260
Biomarkers of rheumatoid arthritis-associated interstitial lung disease: a systematic review and meta-analysis., PMID:39534599
Targeting Human Pancreatic Cancer with a Fluorophore-Conjugated Mucin 4 (MUC4) Antibody: Initial Characterization in Orthotopic Cell Line Mouse Models., PMID:39458160
Should we Continue to Monitor or Choose to Ignore the Mild Increase in CA19-9 after Surgery., PMID:39382905
Effectiveness, safety, and biomarker analysis of lenvatinib plus toripalimab as chemo-free therapy in advanced intrahepatic cholangiocarcinoma: a real-world study., PMID:39358645
Potential of Carbohydrate Antigen 19-9 and Serum Apolipoprotein A2-Isoforms in the Diagnosis of Stage 0 and IA Pancreatic Cancer., PMID:39272705
Tumor-Associated Carbohydrate Antigen 19-9 (CA 19-9), a Promising Target for Antibody-Based Detection, Diagnosis, and Immunotherapy of Cancer., PMID:39230966
Identification of autoantibodies as potential non-invasive biomarkers for intrahepatic cholangiocarcinoma., PMID:39198554
A label-free electrochemical biosensor based on a bimetallic organic framework for the detection of carbohydrate antigen 19-9., PMID:39189647
Analytical interference in CA 19-9 immunoassay generates false-positive results in a young woman with a low-grade appendiceal tumor: An educational case report and brief literature review., PMID:39115286
Hypofractionated radiotherapy plus PD-1 antibody and SOX chemotherapy as second-line therapy in metastatic pancreatic cancer: a single-arm, phase II clinical trial., PMID:39105880
Stem cell-like circulating tumor cells identified by Pep@MNP and their clinical significance in pancreatic cancer metastasis., PMID:38983932
Detection of Tumor-Associated Autoantibodies in the Sera of Pancreatic Cancer Patients Using Engineered MUC1 Glycopeptide Nanoparticle Probes., PMID:38935849
Combined Efficacy of Nimotuzumab and Gemcitabine on the Treatment of Advanced Pancreatic cancer., PMID:38888842
A Curious Case of Autoimmunity, Pancytopenia, and Disseminated Intravascular Coagulation., PMID:38881089
[A Case of BRAF Mutant Cecal Cancer Treated with Encorafenib, Binimetinib, and Cetuximab Triple Therapy]., PMID:38881068
Loss of mucosal tolerance to glycoprotein 2 isoform 1 is a potential novel diagnostic biomarker for cholangiocarcinoma., PMID:38853092
Availability of Serum Levels of Carbohydrate Antigen 19-9 (CA19-9) as a Surrogate Tumor Marker for Papillary Thyroid Carcinoma., PMID:38721086
Significant elevation of serum CA19-9 and CA242 levels induced by dulaglutide., PMID:38719260
Morphology and optical properties of Au-Ag hybrid nanoparticles regulation and its ultra-sensitive SERS immunoassay detection in carbohydrate antigen 19-9., PMID:38663064
Clinical Efficacy and Adverse Effects of Bevacizumab in Combination with Chemotherapy for Metastatic Colorectal Cancer., PMID:38581323
Serum NY-ESO-1 and p53 antibodies as useful tumor markers in gastric cancer., PMID:38455491
Capacitive immunosensing at gold nanoparticle-decorated reduced graphene oxide electrodes fabricated by one-step laser nanostructuration., PMID:38401281
A dual-electrode label-free immunosensor based on in situ prepared Au-MoO3-Chi/porous graphene nanoparticles for point-of-care detection of cholangiocarcinoma., PMID:38364561
[A Case of TMB-High Recurrent Peritoneal Seeding in Hilar Cholangiocarcinoma Treated with Pembrolizumab Therapy]., PMID:38303237
Double-Amplified Electrochemiluminescence Immunoassay Sensor for Highly Sensitive Detection of CA19-9 Using a Ternary Semiconductor CdSSe., PMID:38215346
For research use only. Not for human or drug use.
